Products for Research Use Only
RegisterLogin

Captopril-13C5,15N

CAT: 0804-HY-B0368S1Size: 1 EachDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-B0368S1Size:1 Each
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Captopril-13C5,15N (SQ 14225-13C5,15N) is 13C and 15N labeled Captopril. Captopril (SQ 14225), antihypertensive agent, is a thiol-containing competitive, orally active angiotensin-converting enzyme (ACE) inhibitor (IC50=0.025 μM) and has been widely used for research of hypertension and congestive heart failure. Captopril is also a New Delhi metallo-β-lactamase-1 (NDM-1) inhibitor with an IC50 of 7.9 μM[1][2][3].
Product Name Alternative
SQ 14225-13C5,15N
UNSPSC
12352211
Target
Angiotensin-converting Enzyme (ACE) ; Isotope-Labeled Compounds
Related Pathways
Metabolic Enzyme/Protease; Others
Applications
Cancer-programmed cell death
Field of Research
Cardiovascular Disease; Cancer
Smiles
O=C([C@@H](CS)C)[15N]1[13CH2][13CH2][13CH2][13C@H]1[13C](O)=O
Molecular Formula
C4 13C5H15 15NO3S
Molecular Weight
223.24
References & Citations
[1]Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53 (2) :211-216.|[2]Afrin S, et al. Eritadenine from Edible Mushrooms Inhibits Activity of Angiotensin Converting Enzyme in Vitro. J Agric Food Chem. 2016;64 (11) :2263-2268.|[3]Esmaeili S, et al. Captopril/enalapril inhibit promiscuous esterase activity of carbonic anhydrase at micromolar concentrations: An in vitro study. Chem Biol Interact. 2017;265:24-35.|[4]Li N, et al. Simplified captopril analogues as NDM-1 inhibitors. Bioorg Med Chem Lett. 2014;24 (1) :386-389.|[5]Tzakos, A.G., et al., The molecular basis for the selection of captopril cis and trans conformations by angiotensin I converting enzyme. Bioorg Med Chem Lett, 2006. 16 (19) : p. 5084-7.|[6]Song, J.C. and C.M. White, Clinical pharmacokinetics and selective pharmacodynamics of new angiotensin converting enzyme inhibitors: an update. Clin Pharmacokinet, 2002. 41 (3) : p. 207-24.
Shipping Conditions
Room temperature
Scientific Category
Isotope-Labeled Compounds
Clinical Information
No Development Reported

Related Products

CatalogName
HY-14291S2Vildagliptin-13C5,15N
HY-10984S3Pomalidomide-15N,13C5
HY-18206S2Lisinopril-13C5,15N
HY-A0003S2Lenalidomide-13C5,15N
HY-P0014S1-01Liraglutide-13C5,15N (TFA)
HY-18252S1Avanafil-13C5,15N, d2
HY-16637S4Folic acid-13C5,15N
HY-Y0252S4-01L-Proline-13C5,15N
HY-N0717S1-01L-Valine-13C5,15N
HY-N0326S6-01L-Methionine-13C5,15N

Alternative Products

CatalogName
AR-C01307-01Captopril-13C5
CS-O-16471Vildagliptin-13C5,15N
CS-O-15725Avanafil-13C5,15N
AR-L08119-01Lenalidomide-13C5-15N
AR-P32260-01Pralatrexate-13C5-15N
CS-BU-00128Pomalidomide-15N,13C5
TRC-P755992-10MGD-Proline-13C5,15N
OR1039772L-Proline-13C5,15N
TRC-V094207-5MGL-Valine-13C5,15N
TMIJ-0381-01L-Valine-13C5-15N

Popular Products